Treatment of cerebral aneurysms using haemodynamic implants such as endosaccular flow disruptors and endoluminal flow diverters has gained significant momentum during recent years. The intended target zone of these devices is the immediate interface between the aneurysm and the parent vessel. The therapeutic success is based on the reduction of aneurysmal perfusion and the subsequent formation of a neointima along the surface of the implant.

Juan Gómez Rivas | Urology Consultant, Hospital Clinico San Carlos, Madrid, Spain; Assistant Professor, Universidad Complutense de Madrid, Spain

Cholestatic liver diseases include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and progressive familial intrahepatic cholestasis (PFIC). In all of these conditions, cholestatic itch is a major symptom that can severely and chronically impact a person’s quality of life (QoL).

While there are many ongoing academic efforts to find novel use cases for AI in medicine, radiology is one area in which it can…

WELCOMED by the graceful vocals of the Italian Tenors, Christopher Chapple, European Association of Urology (EAU) Secretary General…

DURING the European Association of Urology (EAU) Congress 2023, experts participated in a series of debates regarding the use of robotic…

Timothy Clinton – Urologic Oncologist and Associate Surgeon, Dana–Farber Cancer Institute and Brigham and Women’s Hospitals, Boston, Massachusetts, USA; Faculty Member, Harvard University, Boston, USA.

David Stukus – Professor of Clinical Pediatrics, Division of Allergy and Immunology; Director, Food Allergy Treatment Center, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA

This year, the European Society of Radiology (ESR) welcomed 17,262 participants from 122 different countries to their congress in Vienna…